ARCHIVES

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

December 13, 2002

2018 State of Cancer Care in America

February 3, 2022

Biopsy System Effective In Removing Benign Breast Masses, Study Finds

May 28, 2004

In Brief: Selection Of NCI Director Extended By Month; Fisher Named NSABP Scientific Director

March 17, 1995

Weicker Compromise on 6,000 Grants For Two Years Holds Up; New Waxman Bill Would Renew Cancer Act

May 17, 1985

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

May 5, 1995